Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Sales $ 1,284,437 $ 3,099,608
Cost of sales (1,040,339) (1,441,696)
Gross profit 244,098 1,657,912
Operating Expenses (Income)    
Selling and marketing 482,677 317,404
General and administrative 6,428,625 6,423,540
Depreciation and amortization 196,438 171,749
Gain from insurance settlement (165,508)
Total operating expenses 6,942,232 6,912,693
Loss from Operations (6,698,134) (5,254,781)
Other Expense (Income)    
Interest expense, net 360,413 611,297
Gains from foreign currency transactions (101,732) (187,660)
Total other expense 258,681 423,637
Net Loss (6,956,815) (5,678,418)
Net loss attributable to non-controlling interest 293,007
Series B preferred stock dividends (721,057) (724,108)
Net Loss Attributable to Common Stockholders $ (7,384,865) $ (6,402,526)
Net Loss per Common Share $ (0.14) $ (0.14)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 54,649,883 44,889,732